Loading…
Impact of LDL apheresis on atheroprotective reverse cholesterol transport pathway in familial hypercholesterolemia
In familial hypercholesterolemia (FH), low HDL cholesterol (HDL-C) levels are associated with functional alterations of HDL particles that reduce their capacity to mediate the reverse cholesterol transport (RCT) pathway. The objective of this study was to evaluate the consequences of LDL apheresis o...
Saved in:
Published in: | Journal of lipid research 2012-04, Vol.53 (4), p.767-775 |
---|---|
Main Authors: | , , , , , , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
cited_by | cdi_FETCH-LOGICAL-c526t-a9f2281efdfcafff68755d59d9218de92db3f8ba03d19a6fbb73ee9de59984553 |
---|---|
cites | cdi_FETCH-LOGICAL-c526t-a9f2281efdfcafff68755d59d9218de92db3f8ba03d19a6fbb73ee9de59984553 |
container_end_page | 775 |
container_issue | 4 |
container_start_page | 767 |
container_title | Journal of lipid research |
container_volume | 53 |
creator | Orsoni, Alexina Villard, Elise F. Bruckert, Eric Robillard, Paul Carrie, Alain Bonnefont-Rousselot, Dominique Chapman, M. John Dallinga-Thie, Geesje M. Le Goff, Wilfried Guerin, Maryse |
description | In familial hypercholesterolemia (FH), low HDL cholesterol (HDL-C) levels are associated with functional alterations of HDL particles that reduce their capacity to mediate the reverse cholesterol transport (RCT) pathway. The objective of this study was to evaluate the consequences of LDL apheresis on the efficacy of the RCT pathway in FH patients. LDL apheresis markedly reduced abnormal accelerated cholesteryl ester transfer protein (CETP)-mediated cholesteryl ester (CE) transfer from HDL to LDL, thus reducing their CE content. Equally, we observed a major decrease (−53%; P < 0.0001) in pre-β1-HDL levels. The capacity of whole plasma to mediate free cholesterol efflux from human macrophages was reduced (−15%; P < 0.02) following LDL apheresis. Such reduction resulted from a marked decrease in the ABCA1-dependent efflux (−71%; P < 0.0001) in the scavenger receptor class B type I-dependent efflux (−21%; P < 0.0001) and in the ABCG1-dependent pathway (−15%; P < 0.04). However, HDL particles isolated from FH patients before and after LDL apheresis displayed a similar capacity to mediate cellular free cholesterol efflux or to deliver CE to hepatic cells. We demonstrate that rapid removal of circulating lipoprotein particles by LDL apheresis transitorily reduces RCT. However, LDL apheresis is without impact on the intrinsic ability of HDL particles to promote either cellular free cholesterol efflux from macrophages or to deliver CE to hepatic cells. |
doi_str_mv | 10.1194/jlr.M024141 |
format | article |
fullrecord | <record><control><sourceid>proquest_doaj_</sourceid><recordid>TN_cdi_doaj_primary_oai_doaj_org_article_ab302637739744ffb160feb20b8c012b</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S002222752040570X</els_id><doaj_id>oai_doaj_org_article_ab302637739744ffb160feb20b8c012b</doaj_id><sourcerecordid>927989254</sourcerecordid><originalsourceid>FETCH-LOGICAL-c526t-a9f2281efdfcafff68755d59d9218de92db3f8ba03d19a6fbb73ee9de59984553</originalsourceid><addsrcrecordid>eNptkktv1DAURiMEokNhxR55hxBK8SNO4g1SVR4daRAbWFt-XDceJXGwM6nm3-OSoWoRK8u-x8e6119RvCb4ghBRfdj38eIbphWpyJNiQzgTZUNr-rTYYExpSWnDz4oXKe0xJlVVk-fFGaWMtRiLTRG3w6TMjIJDu087pKYOIiSfUBiRmvMmTDHMYGa_AIqwQEyATBd6SHMu9miOakxTiDOaMn-rjsiPyKnB9171qDtOEB_gMHj1snjmVJ_g1Wk9L35--fzj6rrcff-6vbrclYbTei6VcJS2BJx1Rjnn6rbh3HJhBSWtBUGtZq7VCjNLhKqd1g0DEBa4EG3FOTsvtqvXBrWXU_SDikcZlJd_DkK8kSrO3vQglWaY1qxpmGiqyjlNauxAU6xbgwnV2fVxdU0HPYA1MOa--0fSx5XRd_ImLJIx3NScZcG7VdD9c-36cifvzjCradU29UIy-_b0WAy_DnlycvDJQN-rEcIhSUEb0QrKq0y-X0kTQ0oR3L2aYHkXDpnDIU_hyPSbh03cs3_TkAG-ApC_ZfEQZTIeRgPWxxyBPDf_X_FvU0vLGw</addsrcrecordid><sourcetype>Open Website</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>927989254</pqid></control><display><type>article</type><title>Impact of LDL apheresis on atheroprotective reverse cholesterol transport pathway in familial hypercholesterolemia</title><source>Open Access: PubMed Central</source><source>ScienceDirect Journals</source><creator>Orsoni, Alexina ; Villard, Elise F. ; Bruckert, Eric ; Robillard, Paul ; Carrie, Alain ; Bonnefont-Rousselot, Dominique ; Chapman, M. John ; Dallinga-Thie, Geesje M. ; Le Goff, Wilfried ; Guerin, Maryse</creator><creatorcontrib>Orsoni, Alexina ; Villard, Elise F. ; Bruckert, Eric ; Robillard, Paul ; Carrie, Alain ; Bonnefont-Rousselot, Dominique ; Chapman, M. John ; Dallinga-Thie, Geesje M. ; Le Goff, Wilfried ; Guerin, Maryse</creatorcontrib><description>In familial hypercholesterolemia (FH), low HDL cholesterol (HDL-C) levels are associated with functional alterations of HDL particles that reduce their capacity to mediate the reverse cholesterol transport (RCT) pathway. The objective of this study was to evaluate the consequences of LDL apheresis on the efficacy of the RCT pathway in FH patients. LDL apheresis markedly reduced abnormal accelerated cholesteryl ester transfer protein (CETP)-mediated cholesteryl ester (CE) transfer from HDL to LDL, thus reducing their CE content. Equally, we observed a major decrease (−53%; P < 0.0001) in pre-β1-HDL levels. The capacity of whole plasma to mediate free cholesterol efflux from human macrophages was reduced (−15%; P < 0.02) following LDL apheresis. Such reduction resulted from a marked decrease in the ABCA1-dependent efflux (−71%; P < 0.0001) in the scavenger receptor class B type I-dependent efflux (−21%; P < 0.0001) and in the ABCG1-dependent pathway (−15%; P < 0.04). However, HDL particles isolated from FH patients before and after LDL apheresis displayed a similar capacity to mediate cellular free cholesterol efflux or to deliver CE to hepatic cells. We demonstrate that rapid removal of circulating lipoprotein particles by LDL apheresis transitorily reduces RCT. However, LDL apheresis is without impact on the intrinsic ability of HDL particles to promote either cellular free cholesterol efflux from macrophages or to deliver CE to hepatic cells.</description><identifier>ISSN: 0022-2275</identifier><identifier>EISSN: 1539-7262</identifier><identifier>DOI: 10.1194/jlr.M024141</identifier><identifier>PMID: 22338009</identifier><language>eng</language><publisher>United States: Elsevier Inc</publisher><subject>Adult ; Animals ; Apolipoproteins B - genetics ; Apolipoproteins B - metabolism ; ATP Binding Cassette Transporter, Subfamily G, Member 1 ; ATP-Binding Cassette Transporters - genetics ; ATP-Binding Cassette Transporters - metabolism ; Biological Transport ; Blood Component Removal - methods ; cellular cholesterol efflux ; CHO Cells ; Cholesterol Ester Transfer Proteins - genetics ; Cholesterol Ester Transfer Proteins - metabolism ; Cholesterol Esters - metabolism ; Cholesterol, HDL - metabolism ; Cholesterol, LDL - isolation & purification ; cholesteryl ester transfer protein ; Cricetinae ; Esterification ; Female ; high density lipoprotein ; high density lipoprotein cholesteryl ester uptake ; High-Density Lipoproteins, Pre-beta - genetics ; High-Density Lipoproteins, Pre-beta - metabolism ; Humans ; Hyperlipoproteinemia Type II - genetics ; Hyperlipoproteinemia Type II - metabolism ; Hyperlipoproteinemia Type II - pathology ; Hyperlipoproteinemia Type II - therapy ; Life Sciences ; Lipid Metabolism ; low density lipoprotein ; Macrophages - metabolism ; Male ; Mice ; Middle Aged ; Scavenger Receptors, Class B - genetics ; Scavenger Receptors, Class B - metabolism ; Young Adult</subject><ispartof>Journal of lipid research, 2012-04, Vol.53 (4), p.767-775</ispartof><rights>2012 © 2012 ASBMB. Currently published by Elsevier Inc; originally published by American Society for Biochemistry and Molecular Biology.</rights><rights>Distributed under a Creative Commons Attribution 4.0 International License</rights><rights>Copyright © 2012 by the American Society for Biochemistry and Molecular Biology, Inc. 2012</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c526t-a9f2281efdfcafff68755d59d9218de92db3f8ba03d19a6fbb73ee9de59984553</citedby><cites>FETCH-LOGICAL-c526t-a9f2281efdfcafff68755d59d9218de92db3f8ba03d19a6fbb73ee9de59984553</cites><orcidid>0000-0003-0150-1360</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC3307653/pdf/$$EPDF$$P50$$Gpubmedcentral$$H</linktopdf><linktohtml>$$Uhttps://www.sciencedirect.com/science/article/pii/S002222752040570X$$EHTML$$P50$$Gelsevier$$Hfree_for_read</linktohtml><link.rule.ids>230,314,727,780,784,885,3549,27924,27925,45780,53791,53793</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/22338009$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink><backlink>$$Uhttps://hal.science/hal-03624876$$DView record in HAL$$Hfree_for_read</backlink></links><search><creatorcontrib>Orsoni, Alexina</creatorcontrib><creatorcontrib>Villard, Elise F.</creatorcontrib><creatorcontrib>Bruckert, Eric</creatorcontrib><creatorcontrib>Robillard, Paul</creatorcontrib><creatorcontrib>Carrie, Alain</creatorcontrib><creatorcontrib>Bonnefont-Rousselot, Dominique</creatorcontrib><creatorcontrib>Chapman, M. John</creatorcontrib><creatorcontrib>Dallinga-Thie, Geesje M.</creatorcontrib><creatorcontrib>Le Goff, Wilfried</creatorcontrib><creatorcontrib>Guerin, Maryse</creatorcontrib><title>Impact of LDL apheresis on atheroprotective reverse cholesterol transport pathway in familial hypercholesterolemia</title><title>Journal of lipid research</title><addtitle>J Lipid Res</addtitle><description>In familial hypercholesterolemia (FH), low HDL cholesterol (HDL-C) levels are associated with functional alterations of HDL particles that reduce their capacity to mediate the reverse cholesterol transport (RCT) pathway. The objective of this study was to evaluate the consequences of LDL apheresis on the efficacy of the RCT pathway in FH patients. LDL apheresis markedly reduced abnormal accelerated cholesteryl ester transfer protein (CETP)-mediated cholesteryl ester (CE) transfer from HDL to LDL, thus reducing their CE content. Equally, we observed a major decrease (−53%; P < 0.0001) in pre-β1-HDL levels. The capacity of whole plasma to mediate free cholesterol efflux from human macrophages was reduced (−15%; P < 0.02) following LDL apheresis. Such reduction resulted from a marked decrease in the ABCA1-dependent efflux (−71%; P < 0.0001) in the scavenger receptor class B type I-dependent efflux (−21%; P < 0.0001) and in the ABCG1-dependent pathway (−15%; P < 0.04). However, HDL particles isolated from FH patients before and after LDL apheresis displayed a similar capacity to mediate cellular free cholesterol efflux or to deliver CE to hepatic cells. We demonstrate that rapid removal of circulating lipoprotein particles by LDL apheresis transitorily reduces RCT. However, LDL apheresis is without impact on the intrinsic ability of HDL particles to promote either cellular free cholesterol efflux from macrophages or to deliver CE to hepatic cells.</description><subject>Adult</subject><subject>Animals</subject><subject>Apolipoproteins B - genetics</subject><subject>Apolipoproteins B - metabolism</subject><subject>ATP Binding Cassette Transporter, Subfamily G, Member 1</subject><subject>ATP-Binding Cassette Transporters - genetics</subject><subject>ATP-Binding Cassette Transporters - metabolism</subject><subject>Biological Transport</subject><subject>Blood Component Removal - methods</subject><subject>cellular cholesterol efflux</subject><subject>CHO Cells</subject><subject>Cholesterol Ester Transfer Proteins - genetics</subject><subject>Cholesterol Ester Transfer Proteins - metabolism</subject><subject>Cholesterol Esters - metabolism</subject><subject>Cholesterol, HDL - metabolism</subject><subject>Cholesterol, LDL - isolation & purification</subject><subject>cholesteryl ester transfer protein</subject><subject>Cricetinae</subject><subject>Esterification</subject><subject>Female</subject><subject>high density lipoprotein</subject><subject>high density lipoprotein cholesteryl ester uptake</subject><subject>High-Density Lipoproteins, Pre-beta - genetics</subject><subject>High-Density Lipoproteins, Pre-beta - metabolism</subject><subject>Humans</subject><subject>Hyperlipoproteinemia Type II - genetics</subject><subject>Hyperlipoproteinemia Type II - metabolism</subject><subject>Hyperlipoproteinemia Type II - pathology</subject><subject>Hyperlipoproteinemia Type II - therapy</subject><subject>Life Sciences</subject><subject>Lipid Metabolism</subject><subject>low density lipoprotein</subject><subject>Macrophages - metabolism</subject><subject>Male</subject><subject>Mice</subject><subject>Middle Aged</subject><subject>Scavenger Receptors, Class B - genetics</subject><subject>Scavenger Receptors, Class B - metabolism</subject><subject>Young Adult</subject><issn>0022-2275</issn><issn>1539-7262</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2012</creationdate><recordtype>article</recordtype><sourceid>DOA</sourceid><recordid>eNptkktv1DAURiMEokNhxR55hxBK8SNO4g1SVR4daRAbWFt-XDceJXGwM6nm3-OSoWoRK8u-x8e6119RvCb4ghBRfdj38eIbphWpyJNiQzgTZUNr-rTYYExpSWnDz4oXKe0xJlVVk-fFGaWMtRiLTRG3w6TMjIJDu087pKYOIiSfUBiRmvMmTDHMYGa_AIqwQEyATBd6SHMu9miOakxTiDOaMn-rjsiPyKnB9171qDtOEB_gMHj1snjmVJ_g1Wk9L35--fzj6rrcff-6vbrclYbTei6VcJS2BJx1Rjnn6rbh3HJhBSWtBUGtZq7VCjNLhKqd1g0DEBa4EG3FOTsvtqvXBrWXU_SDikcZlJd_DkK8kSrO3vQglWaY1qxpmGiqyjlNauxAU6xbgwnV2fVxdU0HPYA1MOa--0fSx5XRd_ImLJIx3NScZcG7VdD9c-36cifvzjCradU29UIy-_b0WAy_DnlycvDJQN-rEcIhSUEb0QrKq0y-X0kTQ0oR3L2aYHkXDpnDIU_hyPSbh03cs3_TkAG-ApC_ZfEQZTIeRgPWxxyBPDf_X_FvU0vLGw</recordid><startdate>201204</startdate><enddate>201204</enddate><creator>Orsoni, Alexina</creator><creator>Villard, Elise F.</creator><creator>Bruckert, Eric</creator><creator>Robillard, Paul</creator><creator>Carrie, Alain</creator><creator>Bonnefont-Rousselot, Dominique</creator><creator>Chapman, M. John</creator><creator>Dallinga-Thie, Geesje M.</creator><creator>Le Goff, Wilfried</creator><creator>Guerin, Maryse</creator><general>Elsevier Inc</general><general>American Society for Biochemistry and Molecular Biology</general><general>The American Society for Biochemistry and Molecular Biology</general><general>Elsevier</general><scope>6I.</scope><scope>AAFTH</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>1XC</scope><scope>5PM</scope><scope>DOA</scope><orcidid>https://orcid.org/0000-0003-0150-1360</orcidid></search><sort><creationdate>201204</creationdate><title>Impact of LDL apheresis on atheroprotective reverse cholesterol transport pathway in familial hypercholesterolemia</title><author>Orsoni, Alexina ; Villard, Elise F. ; Bruckert, Eric ; Robillard, Paul ; Carrie, Alain ; Bonnefont-Rousselot, Dominique ; Chapman, M. John ; Dallinga-Thie, Geesje M. ; Le Goff, Wilfried ; Guerin, Maryse</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c526t-a9f2281efdfcafff68755d59d9218de92db3f8ba03d19a6fbb73ee9de59984553</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2012</creationdate><topic>Adult</topic><topic>Animals</topic><topic>Apolipoproteins B - genetics</topic><topic>Apolipoproteins B - metabolism</topic><topic>ATP Binding Cassette Transporter, Subfamily G, Member 1</topic><topic>ATP-Binding Cassette Transporters - genetics</topic><topic>ATP-Binding Cassette Transporters - metabolism</topic><topic>Biological Transport</topic><topic>Blood Component Removal - methods</topic><topic>cellular cholesterol efflux</topic><topic>CHO Cells</topic><topic>Cholesterol Ester Transfer Proteins - genetics</topic><topic>Cholesterol Ester Transfer Proteins - metabolism</topic><topic>Cholesterol Esters - metabolism</topic><topic>Cholesterol, HDL - metabolism</topic><topic>Cholesterol, LDL - isolation & purification</topic><topic>cholesteryl ester transfer protein</topic><topic>Cricetinae</topic><topic>Esterification</topic><topic>Female</topic><topic>high density lipoprotein</topic><topic>high density lipoprotein cholesteryl ester uptake</topic><topic>High-Density Lipoproteins, Pre-beta - genetics</topic><topic>High-Density Lipoproteins, Pre-beta - metabolism</topic><topic>Humans</topic><topic>Hyperlipoproteinemia Type II - genetics</topic><topic>Hyperlipoproteinemia Type II - metabolism</topic><topic>Hyperlipoproteinemia Type II - pathology</topic><topic>Hyperlipoproteinemia Type II - therapy</topic><topic>Life Sciences</topic><topic>Lipid Metabolism</topic><topic>low density lipoprotein</topic><topic>Macrophages - metabolism</topic><topic>Male</topic><topic>Mice</topic><topic>Middle Aged</topic><topic>Scavenger Receptors, Class B - genetics</topic><topic>Scavenger Receptors, Class B - metabolism</topic><topic>Young Adult</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Orsoni, Alexina</creatorcontrib><creatorcontrib>Villard, Elise F.</creatorcontrib><creatorcontrib>Bruckert, Eric</creatorcontrib><creatorcontrib>Robillard, Paul</creatorcontrib><creatorcontrib>Carrie, Alain</creatorcontrib><creatorcontrib>Bonnefont-Rousselot, Dominique</creatorcontrib><creatorcontrib>Chapman, M. John</creatorcontrib><creatorcontrib>Dallinga-Thie, Geesje M.</creatorcontrib><creatorcontrib>Le Goff, Wilfried</creatorcontrib><creatorcontrib>Guerin, Maryse</creatorcontrib><collection>ScienceDirect Open Access Titles</collection><collection>Elsevier:ScienceDirect:Open Access</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>Hyper Article en Ligne (HAL)</collection><collection>PubMed Central (Full Participant titles)</collection><collection>DOAJ Directory of Open Access Journals</collection><jtitle>Journal of lipid research</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Orsoni, Alexina</au><au>Villard, Elise F.</au><au>Bruckert, Eric</au><au>Robillard, Paul</au><au>Carrie, Alain</au><au>Bonnefont-Rousselot, Dominique</au><au>Chapman, M. John</au><au>Dallinga-Thie, Geesje M.</au><au>Le Goff, Wilfried</au><au>Guerin, Maryse</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Impact of LDL apheresis on atheroprotective reverse cholesterol transport pathway in familial hypercholesterolemia</atitle><jtitle>Journal of lipid research</jtitle><addtitle>J Lipid Res</addtitle><date>2012-04</date><risdate>2012</risdate><volume>53</volume><issue>4</issue><spage>767</spage><epage>775</epage><pages>767-775</pages><issn>0022-2275</issn><eissn>1539-7262</eissn><abstract>In familial hypercholesterolemia (FH), low HDL cholesterol (HDL-C) levels are associated with functional alterations of HDL particles that reduce their capacity to mediate the reverse cholesterol transport (RCT) pathway. The objective of this study was to evaluate the consequences of LDL apheresis on the efficacy of the RCT pathway in FH patients. LDL apheresis markedly reduced abnormal accelerated cholesteryl ester transfer protein (CETP)-mediated cholesteryl ester (CE) transfer from HDL to LDL, thus reducing their CE content. Equally, we observed a major decrease (−53%; P < 0.0001) in pre-β1-HDL levels. The capacity of whole plasma to mediate free cholesterol efflux from human macrophages was reduced (−15%; P < 0.02) following LDL apheresis. Such reduction resulted from a marked decrease in the ABCA1-dependent efflux (−71%; P < 0.0001) in the scavenger receptor class B type I-dependent efflux (−21%; P < 0.0001) and in the ABCG1-dependent pathway (−15%; P < 0.04). However, HDL particles isolated from FH patients before and after LDL apheresis displayed a similar capacity to mediate cellular free cholesterol efflux or to deliver CE to hepatic cells. We demonstrate that rapid removal of circulating lipoprotein particles by LDL apheresis transitorily reduces RCT. However, LDL apheresis is without impact on the intrinsic ability of HDL particles to promote either cellular free cholesterol efflux from macrophages or to deliver CE to hepatic cells.</abstract><cop>United States</cop><pub>Elsevier Inc</pub><pmid>22338009</pmid><doi>10.1194/jlr.M024141</doi><tpages>9</tpages><orcidid>https://orcid.org/0000-0003-0150-1360</orcidid><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0022-2275 |
ispartof | Journal of lipid research, 2012-04, Vol.53 (4), p.767-775 |
issn | 0022-2275 1539-7262 |
language | eng |
recordid | cdi_doaj_primary_oai_doaj_org_article_ab302637739744ffb160feb20b8c012b |
source | Open Access: PubMed Central; ScienceDirect Journals |
subjects | Adult Animals Apolipoproteins B - genetics Apolipoproteins B - metabolism ATP Binding Cassette Transporter, Subfamily G, Member 1 ATP-Binding Cassette Transporters - genetics ATP-Binding Cassette Transporters - metabolism Biological Transport Blood Component Removal - methods cellular cholesterol efflux CHO Cells Cholesterol Ester Transfer Proteins - genetics Cholesterol Ester Transfer Proteins - metabolism Cholesterol Esters - metabolism Cholesterol, HDL - metabolism Cholesterol, LDL - isolation & purification cholesteryl ester transfer protein Cricetinae Esterification Female high density lipoprotein high density lipoprotein cholesteryl ester uptake High-Density Lipoproteins, Pre-beta - genetics High-Density Lipoproteins, Pre-beta - metabolism Humans Hyperlipoproteinemia Type II - genetics Hyperlipoproteinemia Type II - metabolism Hyperlipoproteinemia Type II - pathology Hyperlipoproteinemia Type II - therapy Life Sciences Lipid Metabolism low density lipoprotein Macrophages - metabolism Male Mice Middle Aged Scavenger Receptors, Class B - genetics Scavenger Receptors, Class B - metabolism Young Adult |
title | Impact of LDL apheresis on atheroprotective reverse cholesterol transport pathway in familial hypercholesterolemia |
url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-27T11%3A02%3A50IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_doaj_&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Impact%20of%20LDL%20apheresis%20on%20atheroprotective%20reverse%20cholesterol%20transport%20pathway%20in%20familial%20hypercholesterolemia&rft.jtitle=Journal%20of%20lipid%20research&rft.au=Orsoni,%20Alexina&rft.date=2012-04&rft.volume=53&rft.issue=4&rft.spage=767&rft.epage=775&rft.pages=767-775&rft.issn=0022-2275&rft.eissn=1539-7262&rft_id=info:doi/10.1194/jlr.M024141&rft_dat=%3Cproquest_doaj_%3E927989254%3C/proquest_doaj_%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c526t-a9f2281efdfcafff68755d59d9218de92db3f8ba03d19a6fbb73ee9de59984553%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=927989254&rft_id=info:pmid/22338009&rfr_iscdi=true |